470
Participants
Start Date
October 6, 2012
Primary Completion Date
May 6, 2013
Study Completion Date
June 5, 2013
Fluarix Quadrivalent
1 or 2 doses administered intramuscularly (IM) in deltoid region depending on the priming status
GSK Investigational Site, Prague
GSK Investigational Site, Castellon
GSK Investigational Site, Castellon
GSK Investigational Site, Santiago de Compostela
GSK Investigational Site, Blanes (Girona)
GSK Investigational Site, Odolena Voda
GSK Investigational Site, Madrid
GSK Investigational Site, Antequera/Málaga
GSK Investigational Site, Jindřichův Hradec
GSK Investigational Site, Seville
GSK Investigational Site, Valencia
GSK Investigational Site, Valencia
GSK Investigational Site, Paiporta, Valencia
GSK Investigational Site, Quart de Poblet, Valencia
GSK Investigational Site, Ostrava - Poruba
GSK Investigational Site, Lipník nad Bečvou
GSK Investigational Site, Děčín
GSK Investigational Site, Náchod
GSK Investigational Site, Pardubice
GSK Investigational Site, Tábor
GSK Investigational Site, Dębica
GSK Investigational Site, Katowice
GSK Investigational Site, Siemianowice Śląskie
GSK Investigational Site, Centelles (Barcelona)
GSK Investigational Site, St Austell
GSK Investigational Site, Coventry
GSK Investigational Site, Belfast
GSK Investigational Site, Bristol
GSK Investigational Site, Exeter
GSK Investigational Site, Gloucester
GSK Investigational Site, London
GSK Investigational Site, Oxford
GSK Investigational Site, Southampton
Lead Sponsor
GlaxoSmithKline
INDUSTRY